id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-N-0708-0001,FDA,FDA-2025-N-0708,"Medical Devices; Immunology and Microbiology Devices; Classification of the DNA-Based Test To Measure
Minimal Residual Disease in Hematological Malignancies",Rule,Final Rule,2025-05-09T00:00:00Z,2025,5,2025-05-09T00:00:00Z,,2025-05-21T19:36:21Z,2025-08143,0,0,09000064b8d1ec0d